跳至主要内容
临床试验/NL-OMON55417
NL-OMON55417招募中4 期

Anti-inflammatory effects of tiotropium in patients with stable COPD-A randomized controlled double-blind study - ANTIOFLAM study

niversitair Medisch Centrum Groningen0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Men or women, age >= 40 years
  • post-bronchodilator FEV1 >= 0.8 Litres
  • smoking history of > 10 pack years.
  • Being in a stable phase of COPD, as judged by the investigator. No courses of
  • systemic steroids last 4 weeks
  • Post-bronchodilator FEV1 / FVC ratio < 70% and post-bronchodilator FEV1 <

排除标准

  • Treatment with long-acting anticholinerigcs <4 weeks before the start of the
  • Treatment with corticosteroids <4 weeks before the start of the study.
  • Concomitant diagnosis of asthma.
  • Females of childbearing potential without an efficient contraception unless
  • they meet the following definition of post-menopausal: 12 months of natural
  • (spontaneous) amenorrhea or 6 months of spontaneous amenorrhea with serum FSH
  • >40 mIU/mL or the use of one or more of the following acceptable methods of
  • contraception:
  • a) Surgical sterilization (e.g. bilateral tubal ligation, hysterectomy).
  • b) Hormonal contraception (implantable, patch, oral, injectable).
  • c) Barrier methods of contraception: condom or occlusive cap (diaphragm or
  • cervical/vault caps) with spermicidal foam/gel/cream/suppository.
  • d) Continuous abstinence.

研究者

相似试验